Dave all phara products take years and expense to get to market. But tradiitionally they dont make any revenue along the pathway to regulation. ZLD investor presentations show this clearly.
ZLD products are whole of plant products. Very few in that space. And this along with clinical testing are huge difference makers from any generic CBD oil.
ZLD is doing exactly what it has been saying it will be doing. Worldwide, opinions toward medical cannabis are finally changing. Yes they need more licensing deals. Yes we need more updates on Pain and Parkinson products. And yes we need clearer communication in company communications. But the fundamentals are probably stronger now than they have ever been.
- Forums
- ASX - By Stock
- ZLD
- Ann: Appendix 4C - quarterly
Ann: Appendix 4C - quarterly, page-87
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ZLD (ASX) to my watchlist
|
|||||
Last
80.0¢ |
Change
0.060(8.11%) |
Mkt cap ! $8.396M |
Open | High | Low | Value | Volume |
80.0¢ | 80.0¢ | 80.0¢ | $4.4K | 5.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 680 | 75.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
80.0¢ | 1457 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 680 | 0.750 |
1 | 124 | 0.740 |
1 | 5000 | 0.680 |
1 | 2822 | 0.670 |
2 | 5924 | 0.650 |
Price($) | Vol. | No. |
---|---|---|
0.800 | 28 | 1 |
0.810 | 667 | 1 |
0.850 | 102 | 1 |
0.900 | 400 | 1 |
0.920 | 6500 | 1 |
Last trade - 10.09am 22/08/2024 (20 minute delay) ? |
Featured News
ZLD (ASX) Chart |